Columbus-based OhioHealth reported an operating income of $610.2 million (8.2% margin) in fiscal year 2026, down from a $702.6 million operating income (10.1% margin) the previous year, according to its most recent financial report shared with Becker’s.
OhioHealth did not record a gain on business divestitures in fiscal year 2026, compared with $316.6 million the previous fiscal year, when it sold its home health and hospice business and its outreach laboratory business. The prior-year gain was recorded as operating revenue, which boosted fiscal 2025 operating income.
The system entered into a partnership agreement with a surgery center and became the controlling partner in two prior equity method surgery center joint ventures in fiscal 2026. It also reported $13.3 million in proceeds from the sale of joint ventures in fiscal 2026, though the report did not specify which ventures were sold.
OhioHealth’s total operating revenue was $7.4 billion in fiscal year 2026, up 6.6% year over year. Patient service revenues increased 11.8% to $7.1 billion, and other revenues increased 10.7% to $347.2 million.
The health system’s total operating expenses were $6.8 billion in fiscal 2026, up 8.8% from $6.3 billion in 2025. Salaries and wages were $3.1 billion, up from $3 billion the previous year.
OhioHealth’s net income was $1.5 billion for the year ended June 30, 2026, down from a net income of $1.6 billion in fiscal year 2025. The system’s long-term debt was $1.6 billion as of June 30, 2026, roughly flat with the previous year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
